首页|新诊断2型糖尿病患者血C肽水平与10年内动脉粥样硬化性心血管疾病发生风险的相关性分析

新诊断2型糖尿病患者血C肽水平与10年内动脉粥样硬化性心血管疾病发生风险的相关性分析

扫码查看
目的 分析新诊断2型糖尿病(T2DM)患者血清C肽水平对10年内发生动脉粥样硬化性心血管疾病(ASCVD)的风险的影响。方法 选取新诊断T2DM患者345例,根据空腹C肽(FCP)水平四分位数将患者分为4组,应用China-PAR模型评估10年内发生ASCVD的风险。结果 高FCP水平(>0。980 ng/mL)与较高的10年ASCVD风险相关,且这种关系受性别和体重影响。多元线性回归分析显示,校正性别、年龄、BMI、糖化血红蛋白等混杂因素后,FCP仍然能正向预测10年ASCVD风险。结论 高FCP水平是新诊断T2DM患者未来ASCVD风险的一个危险因素。
Association between C-peptide level and 10-year risk of ASCVD in patients with newly diagnosed type 2 diabetes mellitus
Objective To analyze the impact of serum C-peptide levels in patients with newly diagnosed type 2 diabetes(T2DM)on the 10-year risk of atherosclerotic cardiovascular disease(ASCVD).Methods A total of 345 patients with newly diagnosed T2DM were selected and categorized into four groups based on fasting C-peptide(FCP)level quartiles.The China-PAR model was employed to evaluate the 10-year ASCVD risk.Results Elevated FCP levels(greater than 0.980 ng/ml)were found to be associated with an increased 10-year ASCVD risk with this relationship being moderated by gender and weight.Mul-tiple linear regression analysis indicated that,after adjusting confounding factors such as gender,age,BMI,and glycosylated he-moglobin,FCP levels remained a positive predictor of 10-year ASCVD risk.Conclusion High FCP levels constitute a significant risk factor for future ASCVD in patients with newly diagnosed T2DM.

type 2 diabetesfasting C-peptiderisk of ASCVD

查小云、魏长顺、吴金枝、谢良孝、赖鹏斌

展开 >

福建医科大学附属漳州市医院内分泌代谢一科,漳州 363000

2型糖尿病 空腹C肽 ASCVD风险

2024

福建医药杂志
中华医学会福建分会

福建医药杂志

影响因子:0.525
ISSN:1002-2600
年,卷(期):2024.46(8)